- Product Details
Keywords
- Vipadenant
- BIIB-014
- Vipadenant Chengdu Hneghui Pharm Tec Co. LTD
Quick Details
- ProName: Vipadenant high quality
- CasNo: 442908-10-3
- Molecular Formula: C16H15N7O
- Appearance: off-white powder
- Application: For laboratory use only- not intended ...
- DeliveryTime: 3 days
- PackAge: Aluminum foil bag
- ProductionCapacity: 10 Kilogram/Month
- Purity: ≥98%
- Storage: room temperature
- Transportation: by air
- LimitNum: 10 Milligram
Superiority
Details
Vipadenant is an adenosine receptor antagonist, with Ki of 1.3 nM and 68 nM for A2A and A1, respectively. IC50 & Target: Ki: 1.3 nM (A2A), 68 nM (A1), 1005 nM (A3) In Vivo: Vipadenant (0.3-30 mg/kg) produces a dose-dependent reduction in catalepsy. Vipadenant (10 mg/kg) does not produce any statistically significant dyskinetic episodes in 6-OHDA-lesioned rats during a 19-day dosing regimen[1]. In the mouse and rat haloperidol-induced hypolocomotion models, vipadenant has a minimum effective dose of 0.1 and 1 mg/kg, respectively. Vipadenant (3 and 10 mg/kg, p.o.) is able to increase contralateral rotations in 6-OHDA lesioned rats